title: Analysis of mutations in the SCH gene in schwannomas.
abstract: Schwannomas are benign tumors of cranial, spinal, and other nerve sheaths that develop sporadically or are inherited as part of neurofibromatosis type 2 (NF2). The NF2 gene (SCH) on chromosome 22 has recently been identified and shown to be inactivated by mutation and allele loss in some schwannomas. However, only limited regions in the SCH coding region were examined for mutations. We have extended these studies by screening virtually all coding sequences of the SCH gene (95% coverage) and adjacent splice site sequences for the presence of mutations in 48 schwannomas. All tumors (34 vestibular schwannomas and 14 schwannomas of other locations) were additionally characterized for allele loss on chromosome 22. By PCR-DGGE screening of the 16 known exons of the SCH gene, 22 mutations were found. Most of these give rise to a premature stop codon and are expected to result in the synthesis of a truncated gene product (schwannomin). Although there was no apparent hotspot for mutations, 16 of the 22 mutations occurred in the first eight exons or adjacent splice site sequences of the SCH gene. In several vestibular as well as other schwannomas loss of one SCH allele and mutational inactivation of the second allele were identified in the same tumor. Our data indicate that the SCH gene is implicated in the development of schwannomas of all locations in the nervous system.
authors.affiliation: Institute of Human Genetics, Academic Medical Centre, University of Amsterdam, The Netherlands.
authors.forename: E K
authors.initials: EK
authors.lastname: Bijlsma
authors.forename: P
authors.initials: P
authors.lastname: Merel
authors.forename: D A
authors.initials: DA
authors.lastname: Bosch
authors.forename: A
authors.initials: A
authors.lastname: Westerveld
authors.forename: O
authors.initials: O
authors.lastname: Delattre
authors.forename: G
authors.initials: G
authors.lastname: Thomas
authors.forename: T J
authors.initials: TJ
authors.lastname: Hulsebos
mesh_terms: D000483:Alleles; D001483:Base Sequence; D016543:Central Nervous System Neoplasms / Q000235:genetics; D002892:Chromosomes, Human, Pair 22; D003062:Codon; D003390:Cranial Nerve Neoplasms / Q000235:genetics; D004252:DNA Mutational Analysis; D004273:DNA, Neoplasm / Q000235:genetics*; D005091:Exons; D016515:Genes, Neurofibromatosis 2; D006801:Humans; D008565:Membrane Proteins / Q000235:genetics*; D008969:Molecular Sequence Data; D009363:Neoplasm Proteins / Q000235:genetics*; D009442:Neurilemmoma / Q000235:genetics*; D016518:Neurofibromatosis 2 / Q000235:genetics*; D025581:Neurofibromin 2; D009464:Neuroma, Acoustic / Q000235:genetics*; D010524:Peripheral Nervous System Neoplasms / Q000235:genetics; D017354:Point Mutation; D016133:Polymerase Chain Reaction; D012326:RNA Splicing; D016415:Sequence Alignment; D017384:Sequence Deletion
chemical_list: D003062:Codon; D004273:DNA, Neoplasm; D008565:Membrane Proteins; D009363:Neoplasm Proteins; D025581:Neurofibromin 2